Empowering Orthopaedic Executives through Strategic Intelligence
Mergers & Acquisitions Tracker 1993-2022
M&A transactions increased every year between 2017 and 2020 but have since slowed due to inflated valuations and market disruption. As the market evolves, we're also seeing more transactions outside the spine segment.
Stay on top of the industry's consolidation trend with our refreshed orthopedic M&A Tracker. We've made it easier than ever to integrate decades of transactions into your own analysis. Here's what you get when you purchase the Tracker:
- Raw data for over 500 transactions going back to 1993
- Transaction type, value, and sales multiple where available
- Segment information for all transactions since 2016
- Prebuilt executive summary tables and charts
- The regularly updated file available to download for one year
Transactions are on track for a modest increase in 2022.
Unprecedented market conditions and inflated company valuations in 2021 temporarily slowed consolidation in orthopedics. Smaller acquisitions remain the preferred strategy, and we're anticipating near-term moves from companies like Globus Medical and Enovis.
The distribution of transactions by segment is atypical thus far in 2022.
The spine segment accounts for the most transactions since 2016, with 70% more than the nearest segment of trauma. However, 2022 started slowly for spine transactions. Orthobiologics and trauma, primarily the foot and ankle subsegment, have been the busiest thus far.
Learn which segments are accelerating as the market evolves.